How certain bacteria can prevent the growth of C. difficile spores
Contact-dependent suppression of Clostridioides difficile sporulation by enterococci
This study is looking at how good bacteria in our gut, called enterococci, can help stop the harmful bacteria Clostridioides difficile from growing, and it aims to find out which specific parts of the good bacteria do this, with the hope of discovering new ways to treat infections caused by C. difficile.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project ID | NIH-11094039 on NIH RePORTER |
What this research studies
This research investigates how enterococci, a type of bacteria found in the gut, can inhibit the sporulation of Clostridioides difficile, a harmful bacterium. The researchers aim to identify specific genes in enterococci that contribute to this suppression and understand the interactions between these bacteria at the cellular level. By using advanced laboratory techniques, including genetic screening and co-culture assays, they hope to uncover mechanisms that could lead to new treatments for C. difficile infections. This work is particularly important as C. difficile can cause severe gastrointestinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for C. difficile infections, such as those with a history of antibiotic use or gastrointestinal disorders.
Not a fit: Patients who are not affected by C. difficile infections or do not have risk factors for such infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to prevent or treat C. difficile infections, improving patient outcomes.
How similar studies have performed: While the specific approach of this research is novel, there have been successful studies exploring bacterial interactions that modulate pathogenicity in other contexts.
Where this research is happening
Binghamton, United States
- State University of Ny,binghamton — Binghamton, United States (Active)
Researchers
- Principal investigator: Mckenney, Peter T — State University of Ny,binghamton
- Study coordinator: Mckenney, Peter T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.